Live Breaking News & Updates on Taiho Pharmaceutical Company Ltd

Published: Jan 01, 2021
By Alex Keown
ImmunityBio – Fabio M. Benedetti was named chief strategy officer of California-based ImmunityBio. Benedetti will oversee life-cycle management, pipeline and commercial strategy, including medical affairs. Following the completion of ImmunityBio’s
proposed merger with NantKwest, Benedetti is expected to assume the role of chief strategy officer of the combined company. Benedetti most recently served as chief medical officer for Apollomics, Inc., where he led global clinical development programs including clinical strategy, clinical development, and regulatory affairs. He also previously served as Global CMO at Taiho Pharmaceutical Company, Ltd. and CMO for Taiho Oncology, Inc. Prior to Taiho, he held the positions of senior vice president of Clinical Oncology and CMO at Geron Corporation. He also held roles at Onyx Pharmaceuticals, Millennium Pharmaceuticals, Roche and Bristol-Myers Squibb. ....

New York , United States , Zidong Zhang , Kimberly Lee , Charlotte Russel , Sergei Stetsenko , Bristol Myers Squibb , Betterlife Pharma , Greg Gara , John Fahy , Fabiom Benedetti , Christina Reimer , Geron Corporation , Taiho Oncology Inc , Division Of Pulmonary , Novotech Health , Investor Relations At Raptor Pharmaceuticals , Apollomics Inc , University Of California San Francisco , Onyx Pharmaceuticals , Department Of Medicine , Taiho Pharmaceutical Company Ltd , Investor Relations At Lexicon Pharmaceuticals , China Novotech Health Holdings , Betterlife Pharma Inc , Novotech Holding ,